Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health, Department of Health Systems and Population Health and Institute for Public Health Genetics; and the Bernard J. Tyson Kaiser Permanente School of Medicine. She has a PhD from the University of Washington School of Public Health Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
Genetic testing for cancer risk, cancer-related financial hardship
Social, ethical, and policy implications of genomics and precision health
Henderson JT, Martin A, Patnode CD, Henrikson NB. A synthesis of qualitative studies on patient and caregiver experiences with cognitive impairment screening and diagnosis. Aging Ment Health. 2022 Oct 3:1-12. doi: 10.1080/13607863.2022.2126431. [Epub ahead of print]. PubMed
Blasi PR, Scrol A, Anderson ML, Gray MF, Tiffany B, Fullerton SM, Ralston JD, Leppig KA, Henrikson NB. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation. Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9. PubMed
Henrikson NB, Anderson ML, Dickerson J, Ewing JJ, Garcia R, Keast E, King DA, Lewis C, Locher B, McMullen C, Norris CM, Petrik AF, Ramaprasan A, Rivelli JS, Schneider JL, Shulman L, Tuzzio L, Banegas MP. The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials. 2022 May 13;;23(1):402. doi: 10.1186/s13063-022-06344-3. PubMed
Leppig KA, Rahm AK, Appelbaum P, Aufox S, Bland ST, Buchanan A, Christensen KD, Chung WK, Wright-Clayton E, Crosslin D, Denny J, DeVange S, Gordon A, Green RC, Hakonarson H, Harr MH, Henrikson NB, Hoell C, Holm IA, Kullo IJ, Jarvik GP, Lammers PE, Larson EB, Lindor NM, Marasa M, Myer MF, Perez E, Peterson JF, Pratap S, Prows CA, Ralston JD, Rasouly HM, Roden DM, Sharp RR, Singh R, Shaibi G, Smith ME, Sturm A, Thiese HA, Van Driest SL, Williams J, Williams MS, Wynn J, Zawatsky CL, Weisner GL. The reckoning: the return of genomic results to 1444 participants across the eMERGE3 Network. Genet Med. 2022 May;24(5):1130-1138. doi: 10.1016/j.gim.2022.01.015. Epub 2022 Feb 23. PubMed
Moldestad M, Sayre G, Rinne S, Kaboli PJ, Reddy A, Sanders KM, Mao J, Henrikson NB, Sterling R, Nelson KM, Wong ES. Perspectives on training and working in the VHA: implications for primary care physician recruitment and retention. Acad Med. 2022 Feb 8. doi: 10.1097/ACM.0000000000004619. Online ahead of print. PubMed
Haas CB, Ralston J, Fullerton SM, Scrol A, Henrikson NB. Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system. Front Genet. 2022 Aug 11;13:886650. doi: 10.3389/fgene.2022.886650. eCollection 2022. PubMed
Kelly BJ, Leader AE, Henrikson NB. Editorial: Promising strategies for vaccine messages: the message and the source. Front Public Health. 2022 Aug 31;10:971283. doi: 10.3389/fpubh.2022.971283. eCollection 2022. PubMed
Kauffman TL, Prado YK, Reyes AA, Zepp JM, Sawyer J, White LL, Martucci J, Salas SB, Vertrees S, Rope AF, Weinmann S, Henrikson NB, Lee SS, Feigelson HS, Hunter JE. Feasibility of a traceback approach for using pathology specimens to facilitate genetic testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study protocol. J Pers Med. 2021 Nov 13;11(11):1194. doi: 10.3390/jpm11111194. PubMed
Sterling R, Rinne ST, Reddy A, Moldestad M, Kaboli P, Helfrich CD, Henrikson NB, Nelson KM, Kaminetzky C, Wong ES. Identifying and prioritizing workplace climate predictors of burnout among VHA primary care physicians. J Gen Intern Med. 2021 Jul 29. doi: 10.1007/s11606-021-07006-x. Online ahead of print. PubMed
DiNucci A, Henrikson NB, Jonas MC, Basra S, Blasi P, Brown J, Esplin ED, Hassen D, Hao J, Hu Y, Klinger T, Ladd I, Leppig K, Lewis M, Meyer M, Ney S, Ramaprasan A, Romagnoli K, Salvati Z, Scrol A, Schwiter R, Sheridan L, Somasundaram B, Suwannarat P, Wagner JK, Rahm AK. Feasibility and Assessment of a Cascade Traceback Screening program (FACTS): protocol for a multisite study to implement and assess an ovarian cancer traceback cascade testing program. J Pers Med. 2021 Jun 11;11(6):543. doi: 10.3390/jpm11060543. PubMed
The HCSRN conference is a venue for collaborative work to improve health and health care.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.